Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tucatinib, Palbociclib, and Letrozole in HR+/HER2+ Metastatic Breast Cancer
NCT03054363Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Nov 2017
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucatinib in breast cancer, sponsored by University of Colorado Denver. Started Nov 2017; status: completed.
02
Drugs
tucatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03054363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03054363.